Literature DB >> 9296533

Unifocal cervical Castleman disease in two children.

D Tuerlinckx1, E Bodart, M Delos, M Remacle, J Ninane.   

Abstract

UNLABELLED: Castleman disease (CD) is a benign lymphoproliferative disorder characterized by enlarged hyperplastic lymph nodes. Most observations focus on adult patients. In children the disease is rare, usually localized and may be symptomatic or asymptomatic. We reported two children, 7 and 14 years old respectively, affected by unifocal cervical CD of the hyaline vascular type.
CONCLUSION: Two cases illustrate that CD may mimic a neoplasm and should be considered in presence of a solitary neck mass with specific features on CT and MRI.

Entities:  

Mesh:

Year:  1997        PMID: 9296533     DOI: 10.1007/s004310050693

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  5 in total

1.  Castleman's disease in the retropharyngeal space: CT and MR imaging findings.

Authors:  J H Shin; H K Lee; S Y Kim; S K Khang; S H Park; C G Choi; D C Suh
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

2.  [Castleman's disease : a rare differential diagnosis for Heerfordt's syndrome].

Authors:  R Hirt; U Krause; S Knipping
Journal:  HNO       Date:  2012-12       Impact factor: 1.284

3.  Castleman's disease of the head and neck.

Authors:  Jae-Jun Song; Myung-Ho Jung; Jeong-Soo Woo; Sung-Won Chae; Soon-Jae Hwang; Heung-Man Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-07-09       Impact factor: 2.503

4.  Multicentric Castleman's disease in a child with subpectoral involvement.

Authors:  Polat Koşucu; Ali Ahmetoğlu; Mustafa Imamoğlu; Ali Cay; Umit Cobanoğlu; Halit Reşit Gümele
Journal:  Pediatr Radiol       Date:  2003-05-27

Review 5.  Comprehensive analysis of 225 Castleman's diseases in the oral maxillofacial and neck region: a rare disease revisited.

Authors:  Xiaotong He; Qiong Wang; Yaping Wu; Jiaan Hu; Dongmiao Wang; Bin Qi; Wei Zhang; Yanling Wang; Jie Cheng
Journal:  Clin Oral Investig       Date:  2017-10-04       Impact factor: 3.573

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.